{
  "trial_id": "NCT01657409",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "DO and at least one episode of urgency (urgency severity scale, USS\u22652) or UUI per day as recorded in the 3-day voiding diary.",
      "label": "met"
    },
    {
      "criterion": "All patients had been managed with behavioral modification and treated with a certain number of antimuscarinics for more than 4 weeks before they were enrolled into this trial.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Use of antimuscarinic agent and effective in treatment of lower urinary tract symptoms",
      "label": "triggers"
    },
    {
      "criterion": "Patients with severe cardiopulmonary disease and such as congestive heart failure, arrhythmia, poorly controlled hypertension, not able to receive regular follow-up",
      "label": "unknown"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT01657409",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}